NRT Smoking Cessation Aids in the United Kingdom

Publication Date	August 2006
Publisher	Euromonitor
Product Type	Report
Pages	40
ISBN Number	not applicable
Product Code	EUR00427

Buy this product or for assistance call +44 20 7060 7474

PDF £450.00$749 | €504

FAX Order above formats by FAX

Summary

This Smoking Cessation Aids in the UK report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data (20002005), allowing you to identify the sectors driving growth. It identifies the leading companies, the leading brands and offers strategic analysis of key factors influencing the market be they new product developments, distribution or pricing issues. Forecasts to 2010 illustrate how the market is set to change.

Product coverage: NRT gum, NRT patches, NRT inhalators, other Data coverage: market sizes (historic and forecasts), company shares, brand shares

Why buy this report?

Get a detailed picture of the smoking cessation aids industry
Pinpoint growth sectors and trends and identify factors driving change
Understand the competitive environment, the market's major players and leading brands
Use fiveyear forecasts to assess how the market is predicted to develop

Content

1. Executive Summary
2. Operating Environment
- 2.1 Otc Registration and Classification
- 2.2 Vitamins and Dietary Supplements Registration and Classification
- 2.3 Advertising
- 2.4 Packaging and Labelling
- 2.5 Distribution
- 2.6 DeListing or DeReimbursement
- 2.7 Traditional Remedies
- 2.8 Homoeopathy
- 2.9 Generics
- 2.10 Consumer Expenditure on Health Goods and Medical Services
- 2.11 Life Expectancy
3. Otc Healthcare Sales
- 3.1 Market Performance
- 3.2 Switches
- 3.3 Key Trends and Developments
- 3.4 Competitive Environment
- 3.5 Leading Company Profile: Bayer Plc
- 3.6 Leading Company Profile: Boots Healthcare International
- 3.7 Leading Company Profile: Glaxosmithkline Plc
- 3.8 Leading Company Profile: Johnson & Johnson Msd Ltd
- 3.9 Leading Company Profile: Novartis Pharmaceuticals UK Ltd
- 3.10 Leading Company Profile: Pfizer Consumer Healthcare Ltd
- 3.11 Leading Company Profile: Reckitt Benckiser Plc
- 3.12 Leading Company Profile: Roche Products Ltd
- 3.13 Leading Company Profile: Seven Seas Ltd
- 3.14 Leading Company Profile: Ssl International Plc
- 3.15 Leading Company Profile: Wyeth Consumer Healthcare
- 3.16 Emerging and Niche Companies
- 3.17 Retail Distribution
- 3.18 Retailer Activity and Private Label Trends
- 3.19 Forecast Market Performance
4. Nrt Smoking Cessation Aids Sales
- 4.1 Number of Smokers
- 4.2 Sector Performance
- 4.3 New Product Developments
5.Definitions
List of Summaries
- Summary 1 Otc Healthcare Switches 20042005
- Summary 2 Bayer Plc: Operational Indicators 2004
- Summary 3 Boots Healthcare International: Operational Indicators 2005
- Summary 4 Glaxosmithkline Plc: Operational Indicators 2005
- Summary 5 Johnson & Johnson Msd Ltd: Operational Indicators 2004
- Summary 6 Novartis Ag: Operational Indicators 2004
- Summary 7 Pfizer Inc: Operational Indicators 2004
- Summary 8 Reckitt Benckiser Plc: Operational Indicators 2004
- Summary 9 Roche Products Ltd: Operational Indicators 2004
- Summary 10 Seven Seas Ltd: Operational Indicators 2004
- Summary 11 Ssl International Plc: Operational Indicators 2005
- Summary 12 Wyeth Consumer Healthcare: Operational Indicators 2005
- Summary 13 Nrt Smoking Cessation Aids: New Product Launches 2005
List of Tables
- Table 1 Retail Sales of Homoeopathy 19982005
- Table 2 Consumer Expenditure on Health Goods and Medical Services 20002005
- Table 3 Life Expectancy at Birth 20002005
- Table 4 Sales of Otc Healthcare by Sector: Value 20002005
- Table 5 Sales of Otc Healthcare by Sector: % Value Growth 20002005
- Table 6 Otc Healthcare Company Shares by Retail Value 20012005
- Table 7 Otc Healthcare Brand Shares by Retail Value 20022005
- Table 8 Bayer Plc: Shares of Otc Healthcare by Subsector by Retail Value 20012005
- Table 9 The Boots Co Plc: Shares of Otc Healthcare by Subsector by Retail Value 20012005
- Table 10 Glaxosmithkline Plc: Shares of Otc Healthcare by Subsector by Retail Value 20012005
- Table 11 Johnson & Johnson Msd Ltd: Shares of Otc Healthcare by Subsector by Retail Value 20012005
- Table 12 Novartis Pharmaceuticals UK Ltd: Shares of Otc Healthcare by Subsector by Retail Value 20012005
- Table 13 Pfizer Consumer Healthcare Ltd: Shares of Otc Healthcare by Subsector by Retail Value 20012005
- Table 14 Reckitt Benckiser Plc: Shares of Otc Healthcare by Subsector by Retail Value 20012005
- Table 15 Roche Products Ltd: Shares of Otc Healthcare by Subsector by Retail Value 20012005
- Table 16 Seven Seas Ltd: Shares of Otc Healthcare by Subsector by Retail Value 20012005
- Table 17 Ssl International Plc: Shares of Otc Healthcare by Subsector by Retail Value 20012005
- Table 18 Wyeth Consumer Healthcare: Shares of Otc Healthcare by Subsector by Retail Value 20012005
- Table 19 Sales of Otc Healthcare by Distribution Format: % Analysis 2000/2005
- Table 20 Sales of Otc Healthcare by Sector and Distribution Format: % Analysis 2005
- Table 21 Penetration of Private Label by Sector 20012005
- Table 22 Forecast Sales of Otc Healthcare by Sector: Value 20052010
- Table 23 Forecast Sales of Otc Healthcare by Sector: % Value Growth 20052010
- Table 24 Number of Smokers by Gender 20002005
- Table 25 Sales of Nrt Smoking Cessation Aids by Subsector: Value 20002005
- Table 26 Sales of Nrt Smoking Cessation Aids by Subsector: % Value Growth 20002005
- Table 27 Nrt Smoking Cessation Aids Company Shares by Retail Value 20012005
- Table 28 Nrt Smoking Cessation Aids Brand Shares by Retail Value 20022005
- Table 29 Forecast Sales of Nrt Smoking Cessation Aids by Subsector: Value 20052010
- Table 30 Forecast Sales of Nrt Smoking Cessation Aids by Subsector: % Value Growth 20052010